You are here: Published Weight Loss Studies > Drug Treatment Studies > Fluoxetine (Prozac)
|
Index of published clinical studies related to Topiramate (Topamax), off-label use for weight loss
|
Research articles of clinical studies are listed by publication date, starting with the latest. Click on the title to view the abstract.
Well-designed clinical studies related to Topiramate (Topamax), off-label use for weight loss
Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. [2007 Jan 30]
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. [2007 Feb]
Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. [2005 Jul 15]
Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study. [2005 Jun]
Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. [2004 Oct]
A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. [2004 Nov]
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. [2003 Jun]
Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. [2003 Feb]
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. [2001 Oct]
Other clinical studies related to Topiramate (Topamax), off-label use for weight loss
New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. [2006 Dec]
Topiramate for binge-eating disorder associated with obesity. [2006 Nov]
Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity. [2006 Oct]
Obesity: new perspectives and pharmacotherapies. [2006 Sep-Oct]
Hypothalamic regulatory pathways and potential obesity treatment targets. [2006 Feb]
Topiramate for the treatment of epilepsy and other nervous system disorders. [2006 Jan]
Pharmacologic treatment of obesity. [2006]
Drug-induced weight gain. [2005 Aug]
Pharmacotherapy for obesity. [2005]
Pharmacological therapies for obesity. [2005 Mar]
Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series. [2005 Apr 07]
Meta-analysis: pharmacologic treatment of obesity. [2005 Apr 05]
Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery. [2005 Feb]
Diabesity: are weight loss medications effective? [2005]
Topiramate: a new potential pharmacological treatment for obesity. [2004 Dec]
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. [2005 Jan 25]
Clinical pharmacotherapy for obesity: current drugs and those in advanced development. [2004 Oct]
Targeting metabolic syndrome. [2004 Sep]
Psychotropic drugs in the treatment of obesity: what promise? [2004]
Are mood disorders and obesity related? A review for the mental health professional. [2004 May]
Clinical evaluation of anti-obesity drugs. [2004 Apr]
Pharmacological approaches in the treatment of binge eating disorder. [2004 Apr]
Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. [2003 May]
Academy for Eating Disorders International Conference on Eating Disorders. Denver, CO, USA, May 29-31, 2003. [2003 Aug]
Safety of available agents used to treat bipolar disorder: focus on weight gain. [2003 May]
Topiramate effectiveness in Prader-Willi syndrome. [2003 Feb]
Predictors of weight loss in adults with topiramate-treated epilepsy. [2003 Apr]
Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review. [2002 Oct]
Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. [2002 Oct]
Some common issues in the use of antiepileptic drugs. [2002 Mar]
Do obese depressed patients respond to topiramate? A retrospective chart review. [2002 May]
Topiramate use in obese patients with binge eating disorder: an open study. [2002 Apr]
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. [2002]
[Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports] [2002 Feb]
Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. [2001 Apr]
Treatment of affective disorder and obesity with topiramate. [2000 Nov]
Treatment of binge-eating disorder with topiramate: a clinical case series. [2000 May]
|
